ABSTRACT
INTRODUCTION
Ghrelin is a noval polypeptide hormone predominantly synthesized by the stomach and involved in food intake regulation.
(1) Ghrelin was identified as an endogenous ligand for an orphan receptor termed GHsecretagogue receptor possessing potent GH releasing activity.
(2)
Previous studies conducted in healthy children and adolescents revealed that ghrelin levels reach a peak in early post natal life and then gradually decrease during childhood and adolescence. The precise mechanisms underlying these changes have not been fully elucidated.
(4)
Further studies have suggested that androgen and ghrelin may reciprocally cross-talk, Gonadal tissues have in fact been proposed as a target for ghrelin action based on a higher number of binding sites in both ovary and testis. In addition to this first descriptive evidence that ghrelin might play a role in regulation of reproductive physiology, one study has shown that ghrelin affects the chorionic gonodotropin and cAMP induced testosterone secretion in rat testis by inhibiting key enzymes of steroidogenic pathway, (6) Moreover, it has been demonstrated that gonads are not only target tissues for ghrelin, but also relevant sites of ghrelin production, in both testis and ovary, ghrelin is co-expressed with sex hormones in androgen producing cells like leydig and hilus interstitial cells.
(7)
The hypthalmo-pituitary mechanism by which testosterone promotes GH secretion and there by elevates insulin-like growth factor-I (IGF-I) concentration in human are unknown.
(8)
The mechanisms by which sex hormones, particularly androgen may regulate ghrelin expression and secretion are still poorly defined, moreover, it is still undefined whether their regulatory capacity could be influenced by the interference of other hormones and factors.
(5)
So the aim of the present work is to study the role of testosterone replacement therapy on plasma ghrelin level before and after orchiectomy in male albino rats.
MATERIAL & METHODS
45 male albino rats weighing between (250-350 g) were used in this study, they were kept under constant environmental and nutritional conditions through out the experiment. Rats were randomly divided into four groups Group I: Control animals underwent a sham orchiectomy and received no medications for 4 weeks (n= 8). Group II: Control animals underwent a sham orchiectomy and received testosterone propionate (T.P) 300 µg/Kg subcutaneously (s.c) daily for 4 weeks.
(9) (n= 10) Group III: The animals underwent an orchiectomy at the start of the experimental protocol and received no medications for the length of the protocol 4 weeks (n= 12). Group IV: The animals underwent a surgical orchiectomy and received s.c (T.P) 300 µg/Kg daily for 4 weeks (n= 15). At the end of experimental periods, blood samples withdrawn into EDTA containing tubes for plasma and serum samples were taken in the morning after an over night fast. Body weight was measured from all studied animals at the end of experimental periods.
Methods:
 Determination of serum level of total and free testosterone by enzyme immunoassay in rat serum. Quantitative determination for rat ghrelin:
Plasma levels of ghrelin were assayed using reagent kits and methods provided by Kamiya BioMedical Company. Samples were collected in tubes containing EDTA. 2Na (1.25 mg/ ml blood) and aprotinin (500 units/ml blood). Plasma ghrelin determined by 2 sites sandwich enzyme linked immunosorbent assay (ELISA), measure the absorbance at 450 nm. Weigh and anesthetize the animal. Bilateral orchiectomy was performed as described by Svensson et al.
(14) a small surgical incision was made in the center of the scrotum, each testicle was exposed through the surgical orifice. The ductus deferens and main arteries and veins were isolated and ligated. Subsequently the duct and blood vessels were severed allowing the testicle and epididymis to be removed. The incision was then closed, sutured and swabbed with iodine solution. The sham operation involved the exposure of the testis without excision.
The post operative procedure was implemented by proper antibiotics, finally the rats were housed in separate cages and allowed free access to food and water.
Statistical analysis:
Data analyses were performed with the soft ware package SPSS program version 11, the results of continuous variables are presented as mean +SD and statistically analyzed using the unpaired "t" test. Pearson's and spear man's correlation were applied to examine the relationships among ghrelin and the other studied parameters.
RESULTS
Five rats died during the experimental period two from group III and three from group IV Subcutaneous administration of T.P to sham operated rats produces significant increase in serum level of total T and free T when compared to normal control (P<0.05) (table1 & fig  1, 2), also it produces significant reduction in FSH and LH (P<0.05), when compared with control (table 1&  fig 3,4) .
As regard the effect of T.P supplementation on plasma ghrelin level it produces significant increase (P<0.05), this values corresponding to significant increase in IGF-1 (P<0.05). T.P supplementation to orchiectomized rats produce significant increase in total T and free T when compared to orchiectomy group, but it produces significant decrease in FSH and LH (P<0.05)
Ghrelin level was significantly higher after T.P supplementation, also this corresponding with significant increase in IGF-I (P<0.05) when compared with orchiectomy group (table 1 & As regards the effect of T.P supplementation in sham operated and orchiectomy in rats it produces significant weight gain in both groups (P<0.05) when compared the results with either sham operated orchiectomy or orchiectomy respectively (table1 & fig7).
There are +ve correlation between ghrelin level and testosterone level (both total and free), IGF-1 and body weight ( 
DISCUSSION
In our present study, we have attempted to examine the possible role and mechanism of action of testosterone replacement therapy on plasma ghrelin level before and after orchiectomy in male albino rats. It is clear from the present results that s.c administration of T.P to sham operated and orchiectomy rats produces significant decrease in FSH and LH, however it produces significant increase in total testosterone, free testosterone, ghrelin, IGF-I and total body weight.
Our results can be partly explained by previous research finding, that androgen play an important regulatory role regarding ghrelin secretion or catabolism. Also the relationship between androgen and ghrelin is positive in male individuals. The normalization of the androgen status rather than an unnatural increase or decrease may recover suppressed ghrelin secretion and may possibly reestablish a balanced energy homeostasis.
(20)
The mechanism by which testosterone level alter ghrelin concentration may be explained by that testosterone may act directly on both peptide expression and synthesis as well as on ghrelin metabolic pathway.
(16)
Another explanation is that testosterone substitution normalize serum leptin secretion in hypogonadal patient, we can therefore hypothesize that leptin normalization may be involved in elevation of ghrelin levels.
(21)
Testosterone supplementation significantly increase in body weight in sham operated and orchiectomy rats (tab1 & fig7).
Testosterone induces an increase in free fatty acid (FFA) release from the visceral fat depot. Additionally it has been shown that a fat rich diet known to increase circulating FFA, was able to increase circulating ghrelin levels in experimental rats. The significant decrease in FSH and LH observed in this work in sham operated and orchiectomy rats treated by T.P could be explained by increase in ghrelin level in this work (table1) may participate in the regulation of gonadotropin secretion. It is clear from the present work that testosterone supplementation in Gp II and Gp IV produces significant increase in IGF-I (table 1& fig 6) .
These results were in agreement with the previous reports Thomas et al. (30) who reported that supraphysiological testosterone concentration augment GH and IGF-1 production in elderly male.
(30)
In animals pulsatile GH secretion is controlled jointly via feed forward by GH releasing hormone and ghrelin (a GH releasing peptide), Low et al. (8) reported that the hypothalamopituitary mechanism by which testosterone promotes GH secretion and therapy elevates IGF-1 in animals could be due to that hormone.
(8) In this work the elevated ghrelin level after testosterone supplementation (table1 & fig 6) could be one of the mechanisms to increase IGF-1 via increasing level of GH.
(31)
We can conclude that plasma ghrelin level significantly increase after testosterone supplementation in 
